Autoantibodies and Arrhythmias: An Underexplored Link in Myocarditis

Myocarditis is an inflammatory disease that may be associated with severe acute and chronic complications, including progression to inflammatory cardiomyopathy, characterized by persistent inflammation, cardiac dysfunction, and adverse ventricular remodeling. Arrhythmias are major determinants of morbidity and mortality across this disease spectrum and have traditionally been attributed to structural substrates such as myocardial edema, necrosis, and fibrosis. However, as the role of the immune system in myocarditis is increasingly recognized, growing attention has been focused on immune-mediated mechanisms capable of directly perturbing cardiac excitability. Circulating cardiac autoantibodies are frequently detected in patients with myocarditis. Beyond their potential diagnostic value, specific autoantibody subsets have been hypothesized to exert pathogenic effects by targeting receptors, ion channels, contractile proteins, and intercalated disk components involved in impulse generation, conduction, repolarization, calcium handling, and myocardial structural integrity. This narrative review evaluates the mechanistic basis of autoimmune arrhythmias, the available preclinical and clinical evidence linking autoantibodies to atrial and ventricular arrhythmias, and the potential role of autoantibody profiling in refining arrhythmic risk stratification. Particular attention is given to distinguishing direct evidence obtained in patients with myocarditis and inflammatory cardiomyopathy from findings derived from other cardiac or systemic diseases and experimental models, whose applicability to myocardial inflammatory disorders remains uncertain. Finally, we critically evaluate whether autoantibody testing may help identify patients more likely to benefit from immunomodulatory or immunosuppressive strategies, while emphasizing the current limitations related to small observational cohorts and the lack of randomized trials evaluating antibody-guided treatment strategies with dedicated arrhythmic endpoints.

Authors

Institutions

Publication Details

Journal
Journal of Cardiovascular Development and Disease
Published
2026-11-16
DOI
https://doi.org/10.3390/jcdd13110598
Primary Topic
Viral Infections and Immunology Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Autoantibodies and Arrhythmias: An Underexplored Link in Myocarditis

Francesco Tona, Giovanni Civieri, Marta Vadori, Donatella Tansella et al.
Journal of Cardiovascular Development and Disease
Viral Infections and Immunology Research
article

Autoantibodies and Arrhythmias: An Underexplored Link in Myocarditis

Francesco Tona, Giovanni Civieri, Marta Vadori, Donatella Tansella, Laura Iop, Alberto Marmai, Emanuele Cozzi
article en

Abstract

Myocarditis is an inflammatory disease that may be associated with severe acute and chronic complications, including progression to inflammatory cardiomyopathy, characterized by persistent inflammation, cardiac dysfunction, and adverse ventricular remodeling. Arrhythmias are major determinants of morbidity and mortality across this disease spectrum and have traditionally been attributed to structural substrates such as myocardial edema, necrosis, and fibrosis. However, as the role of the immune system in myocarditis is increasingly recognized, growing attention has been focused on immune-mediated mechanisms capable of directly perturbing cardiac excitability. Circulating cardiac autoantibodies are frequently detected in patients with myocarditis. Beyond their potential diagnostic value, specific autoantibody subsets have been hypothesized to exert pathogenic effects by targeting receptors, ion channels, contractile proteins, and intercalated disk components involved in impulse generation, conduction, repolarization, calcium handling, and myocardial structural integrity. This narrative review evaluates the mechanistic basis of autoimmune arrhythmias, the available preclinical and clinical evidence linking autoantibodies to atrial and ventricular arrhythmias, and the potential role of autoantibody profiling in refining arrhythmic risk stratification. Particular attention is given to distinguishing direct evidence obtained in patients with myocarditis and inflammatory cardiomyopathy from findings derived from other cardiac or systemic diseases and experimental models, whose applicability to myocardial inflammatory disorders remains uncertain. Finally, we critically evaluate whether autoantibody testing may help identify patients more likely to benefit from immunomodulatory or immunosuppressive strategies, while emphasizing the current limitations related to small observational cohorts and the lack of randomized trials evaluating antibody-guided treatment strategies with dedicated arrhythmic endpoints.

Journal of Cardiovascular Development and DiseaseVol. 13(11)
University of Padua (IT)
Viral Infections and Immunology Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon